SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is experiencing intense bullish momentum, driven by spot silver prices reaching new all-time highs. This rally is fueled by tightening global supply due to upcoming Chinese export restrictions, alongside booming industrial demand from EV batteries, solar, and AI data centers. The community is actively discussing a potential 'silver squeeze' and a significant re-rating of silver's value, though some anticipate a near-term pullback after its rapid ascent.

Polkadot is a platform that allows diverse blockchains to transfer messages, including value, in a trust-free fashion; sharing their unique features while pooling their security. In brief, Polkadot is a scalable heterogeneous multi-chain technology.  Polkadot is heterogeneous because it is entirely flexible and makes no assumption about the nature or structure of the chains in the network. Even non-blockchain systems or data structures can become parachains if they fulfill a set of criteria.  Polkadot may be considered equivalent to a set of independent chains (e.g. a set containing Ethereum, Ethereum Classic, Namecoin and Bitcoin) except with important additions: pooled security and trust-free interchain transactability.  Many of the native parachains of Polkadot will be written using a Polkadot Runtime Environment SDK (e.g. Parity Technologies' Substrate).

Polkadot

Polkadot (DOT CRYPTO) is trending as the community keenly discusses its upcoming Polkadot 2.0 upgrade, which promises elastic scaling and a flexible Coretime model, alongside a recent decision to implement a 2.1 billion token supply cap. This move towards long-term scarcity and a more adaptable blockchain structure has sparked a polarized debate, with many accumulating and staking in anticipation of future growth, while others express concerns over recent price volatility.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending after receiving FDA approval for YARTEMLEA, its first-in-class drug for TA-TMA, a significant catalyst that the community believes de-risks the company and unlocks substantial value. Investors are discussing its promising pipeline, a major licensing deal with Novo Nordisk, and a strong balance sheet, leading to expectations of significant upside and potential for a short squeeze as many believe the stock remains undervalued. The upcoming conference call is also a key talking point, with hopes for further positive updates.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver Corporation is trending as silver prices soar to new all-time highs, with the community actively discussing impressive spot prices, including significant surges reported in Asian markets. Despite widespread excitement for silver's performance, investors express frustration that AG's stock is lagging this metal rally, fueling speculation about market manipulation while anticipating a substantial "catch-up" revaluation for silver miners. The overarching sentiment points to strong conviction in silver's intrinsic value driven by industrial demand and a belief that a short squeeze or significant upward move for miners is imminent.

abrdn ETF - abrdn Physical Silver Shares ETF

SIVR is trending as silver surges to fresh multi-year highs, captivating community discussions with widespread optimism for continued gains. This rally is primarily fueled by robust safe-haven demand, expectations of looser monetary policy, and tightening supply amidst growing industrial use. Many investors are actively discussing silver's potential for further upside, especially given its historical performance relative to gold and broader macroeconomic uncertainties.

Simplify Exchange Traded Funds - Simplify US Equity PLUS Bitcoin Strategy ETF

Simplify US Equity PLUS GBTC ETF

SPBC, the Simplify US Equity PLUS GBTC ETF, is trending as investors discuss its dual exposure to the S&P 500 and a Bitcoin component via GBTC. A notable decrease in short interest is fueling conversation, with the community actively comparing its performance to broader market indices and considering its role as a diversified option for crypto-adjacent investment strategies.

Coupang, Inc. engages in the provision of retail, restaurant delivery, video streaming, and fintech services to customers around the world under brands that include Coupang, Coupang Eats, Coupang Play, and Farfetch. It operates through the Product Commerce and Developing Offerings segments. The Product Commerce segment consists of the company's core retail and marketplace offerings and Rocket Fresh, its fresh grocery category offering. It also includes advertising products associated with these offerings. The Developing Offerings segment covers the company's more nascent offerings and services including: Coupang Eats, a restaurant ordering and delivery service in Korea, Coupang Play, an online content streaming service in Korea, fintech services, retail operations in Taiwan, as well as advertising products associated with these offerings. It also includes Farfetch, a global luxury fashion marketplace. The company was founded by Bom Kim in 2010 and is headquartered in Seattle, WA.

Coupang Inc - Ordinary Shares - Class A

Coupang Inc 

Coupang is trending amid significant controversy surrounding a massive data breach that has exposed millions of user accounts, fueling widespread public and governmental outrage in South Korea. Community discussions are sharply divided, with many concerned about potential fines and consumer boycotts impacting its core market, while others view the recent sell-off as a compelling long-term buying opportunity given its strong market position and "addictive" service in the region.

abrdn ETF - abrdn Physical Platinum Shares ETF

PPLT is experiencing a parabolic surge, fueled by a confluence of structural supply deficits, strong industrial demand from automotive catalysts and green energy, and geopolitical concerns affecting key producers. The community is aggressively chasing this rally, viewing it as a long-overdue breakout for the historically undervalued and rarer metal, with many anticipating continued upward momentum.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano (ADA) is trending with sharply divided sentiment following significant price declines, prompting widespread accusations of it being a "scam" and "rugpull." While many express extreme bearish views and criticize its founder's perceived shift in focus, a vocal bullish contingent sees current levels as an unparalleled accumulation opportunity for substantial future gains. This intense polarization reflects broader market uncertainty, with investors actively debating the asset's long-term viability within the volatile crypto landscape.

ProShares Trust - ProShares Ultra Silver 2x Shares

ProShares Trust - ProShares Ultra Silver

ProShares Ultra Silver ($AGQ) is experiencing significant attention, driven by fervent community discussions around a potential "silver squeeze" and reports of silver prices surging, particularly in China. Investors are keenly focused on silver's perceived undervaluation relative to gold and its growing industrial demand from sectors like AI and EVs, fueling widespread anticipation of substantial future gains despite historical volatility and manipulation concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FDA Issues CRL to SNY's Regulatory Filing for Multiple Sclerosis Drug

Sanofi receives an FDA CRL for tolebrutinib in nrSPMS after multiple review extensions. The EC clears Wayrilz for treating immune thrombocytopenia.

AGIO's Mitapivat Gets FDA Nod for Thalassemia Indication with REMS in Label

Agios Pharmaceuticals wins FDA approval for Aqvesme in alpha- and beta-thalassemia, making mitapivat the only approved option, despite a new REMS.

Sanofi to Buy Dynavax for $2.2B to Boost Adult Vaccine Franchise

SNY's $2.2 billion deal for Dynavax adds Heplisav-B, a shingles candidate, and other vaccine programs, strengthening its adult vaccine franchise and pipeline.

What Makes Castle Biosciences (CSTL) a Good Fit for 'Trend Investing'

Castle Biosciences (CSTL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

GILD Exercises Option to License Assembly Bio's Herpes Programs

Gilead exercises its option to license ASMB's HSV programs for developing long-acting candidates, ABI-1179 & ABI-5366, for recurrent genital herpes.

CRSP Stock Rises on Encouraging Early Data From Zugo-Cel Studies

CRISPR Therapeutics shares jump after early zugo-cel study data show sustained B-cell depletion and early efficacy across autoimmune and cancer studies.

JNJ's Tremfya Gets EU Approval for Pediatric Plaque Psoriasis

Johnson & Johnson wins EU approval for Tremfya in pediatric plaque psoriasis, making it the first IL-23 inhibitor cleared for any pediatric condition.

AZN, Daiichi's Enhertu Gets FDA Nod for First-Line Breast Cancer (Revised)

AstraZeneca's Enhertu wins FDA nod as a first-line treatment for HER2-positive metastatic breast cancer.

AZN, Daiichi's Enhertu Gets Breakthrough Tag for Expanded Cancer Use

AstraZeneca's Enhertu wins FDA Breakthrough tag for expanded use in breast cancer, while a late-stage study on ceralasertib + Imfinzi in lung cancer misses its goal.

Castle Biosciences (NASDAQ:CSTL) Hits New 12-Month High After Analyst Upgrade

Castle Biosciences (NASDAQ:CSTL) Sets New 1-Year High After Analyst Upgrade...

Castle Biosciences, Inc.is a molecular diagnostics company offering innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.

CSTL
Castle Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CSTL News

CSTLCastle Biosciences Inc